CD19-targeted CAR T-cell therapy (clinical trial)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD19-targeted CAR T-cell therapy (clinical trial), covering 2025-09-23 to 2025-09-23. Get the full timeline:
Most recent: Clinical Trial Update: Immunotherapy for High Risk/Relapsed CD19+ Acute Lymphoblastic Leukaemia, B-cell Non-Hodgkin's Lymphoma (B-NHL) and Chronic Lymphocytic Leukaemia (CLL)/ Small Lymphocytic Lymphoma (SLL) Using CAR T-cells to Target CD19 [Phase 1]